BPG is committed to discovery and dissemination of knowledge
Article Citation
Zhou J, Chen JR, Li JM, Han SQ, Deng XY, Li ZM, Tong W, Wang C, Bai Y, Zhang YM. IL-22/IL-22R1 pathway enhances cholangiocarcinoma progression via ERK1/2 activation. World J Gastrointest Oncol 2025; 17(3): 102083 [PMID: 40092929 DOI: 10.4251/wjgo.v17.i3.102083]
Please LOGIN to submit a new comment.
Write to the Help Desk